Who
In numbers
- Trades disclosed
- 5
- Buys
- 1
- Sells
- 0
- Bought
- $6,320
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 Jun 2023
- Last trade
- 12 Jun 2025
- Last filed
- 14 Apr 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2025filed 12 Jun 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $6,3201,000 at $6.32 | filing |
| 16 Apr 2025filed 14 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 16 Apr 2025filed 14 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 20 Sep 2024filed 24 Sep 2024 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $36K10,000 at $3.60 | filing |
| 28 Jun 2023filed 30 Aug 2023 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $77K15,000 at $5.11 | filing |
News
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales ResultsICCC · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Bryan K. Gathagan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.